NASDAQ$CDLX

Cardlytics Inc · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Cardlytics' Q4 2020 financial results showed a slight decrease in revenue compared to the previous year, but exceeded prior guidance. The company reported a net loss and a decrease in billings, but saw an increase in average FI MAUs.

Cardlytics announced its Q4 2020 financial results, with total revenue decreasing by 3.2% to $67.1 million compared to Q4 2019. The company reported a net loss attributable to common stockholders of $(6.8) million, or $(0.24) per diluted share, and a non-GAAP net loss of $(1.5) million, or $(0.05) per diluted share. Average FI MAUs increased by 22.6% to 163.6 million, while ARPU decreased by 21.2% to $0.41.

  • Total revenue decreased by 3.2% to $67.1 million compared to Q4 2019.
  • Net loss attributable to common stockholders was $(6.8) million, or $(0.24) per diluted share.
  • Non-GAAP net loss was $(1.5) million, or $(0.05) per diluted share.
  • Average FI MAUs increased by 22.6% to 163.6 million, while ARPU decreased by 21.2% to $0.41.

Headline financials

Total Revenue

$67.1M

Previous: $69.3M-3.2%
EPS (adj)

-$0.05

Previous: $0.18-127.8%
Capital Expenditures

$2.72M

No prior period
Free Cash Flow

$2.9M

No prior period
Net Income

-$6.78M

Previous: $3.43M-297.8%
Operating Income

-$6.12M

Previous: $1.26M-586.9%
Gross Profit

$24.8M

No prior period
Cash & Equivalents

$293M

Previous: $104M+180.7%
Total Assets

$423M

No prior period
Stock-Based Comp

$7.59M

No prior period

Revenue & EPS history

Cardlytics · Revenue · Quarterly

$67.1M

Q4 2020-3.2%vs Q4 2019
Beat estimate in 5 of 15 quarters(33%)
ActualEstimate

Forward guidance

Cardlytics anticipates billings, revenue, and adjusted contribution to be in the following ranges (in millions):

Tailwinds

  • Q1 2021 Billings: $67.0 - $75.0 million
  • Q1 2021 Revenue: $47.0 - $53.0 million
  • Q1 2021 Adjusted contribution: $20.0 - $24.0 million
  • FY 2021 Billings: $360.0 - $400.0 million
  • FY 2021 Revenue: $250.0 - $275.0 million

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-6.1%

Avg return

Earnings day

-6.2%

Avg return

5 days after

+14.5%

Avg return

30 days after

47%

16 / 34 earnings

Positive

+68.6%

Q4 2023

Best reaction

-59.6%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.0%-15.0%+654.7%
Q4 2025-9.9%-21.8%+25.6%
Q3 2025-28.5%-16.5%-37.5%
Q1 2025-13.0%-2.8%-17.1%
Q4 2024+4.5%+18.7%-25.3%
Q3 2024-13.2%-3.0%-15.8%
Q2 2024-59.6%-51.9%-53.1%
Q1 2024-39.8%-40.8%-43.4%
Q4 2023+68.6%+64.0%+57.8%
Q3 2023-55.7%-47.6%-40.1%
Q2 2023+15.7%+21.2%+42.8%
Q1 2023-26.0%-29.4%-29.9%
Q4 2022-10.8%-9.4%-37.7%
Q3 2022-52.2%-51.2%-52.9%
Q2 2022+18.3%+10.6%-7.6%
Q1 2022+10.2%-8.5%-24.2%
Q4 2021+5.7%-7.1%-5.2%
Q3 2021+6.7%+8.3%-20.4%
Q2 2021-32.5%-29.2%-22.3%
Q1 2021-20.6%-24.8%-24.2%
Q4 2020+1.2%-3.3%-17.2%
Q3 2020+2.9%+22.7%+56.5%
Q2 2020-9.1%-8.9%+0.8%
Q1 2020+13.0%+8.9%+50.9%
Q4 2019-36.4%-43.7%-64.3%
Q3 2019+43.6%+42.9%+44.4%
Q2 2019+20.0%+24.1%+39.8%
Q1 2019+20.9%+14.8%+47.1%
Q4 2018-5.6%-11.7%-7.2%
Q3 2018-24.9%-19.9%-29.3%
Q2 2018+0.3%+3.0%+27.3%
Q2 2017+0.3%+3.0%+27.3%
Q1 2018-1.0%-7.4%+6.5%
Q4 2017+1.0%+0.5%-13.6%
Q3 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro